This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Norman E. Sharpless, M.D. (Acting), Commissioner of Food and Drugs

No Significant Event

Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner

Event Date: 04/16/2019
Location: Washington, DC
Subject: Roundtable on Sharing and Utilizing Health Data for Al Applications
FDA Participant/Group: N/A
Non FDA Participant/Group: Mona Siddiqui,Ed Simcox, Eric Hargan, Kristen Finne (U.S. Department of Health & Human Services); Joel Gurin (The Center for Open Data Enterprise);Sohini Chowdhury (Michael J. Fox Foundation); Jason Jones (Health Catalyst); Vivian Lee (Verily Life Sciences LLC); Lisa Bari (Center for Medicare and Medicaid Innovation Center);Chris Boone (Pfizer Inc.); Tim Persons (U.S. Government Accountability Office)

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Lowell J. Schiller, Principal Associate Commissioner for Polcy

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

Event Date: 04/17/2019
Location: Silver Spring, MD
Subject: FDA-Embassy of Israel Workshop: Digital Health Collaboration
FDA Participant/Group: RAVI BHARWANI, SEMA HASHEMI, RYAN HOSHI, MELISSA TORRES, LEIGH VERBOIS
Non FDA Participant/Group: Shelly Korenboim, Yifat Perel (Embassy of Israel to the United States);

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 04/15/2019
Location: Silver Spring, MD
Subject: Labeling Exemption Meeting
FDA Participant/Group: NINA ZIMDAHL; DOUGLAS STEARN; DOUGLAS TICKER;
Non FDA Participant/Group: Anthony Zografos (SafeTraces, Inc.);

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Keagan Lenihan, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date: 04/15/2019
Location: Orlando, FL
Subject: 2019 Muscular Dystrophy Association Clinical and Scientific Conference: CDER's Role
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: N/A

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 04/17/2019
Location: College Park, MD
Subject: Mitigation Strategies to Protect Food Against Intentional Adulteration: Draft Guidance for Industry
FDA Participant/Group: JON-MIKEL WOODY; COLIN BARTHEL; KARI BARRETT; RYAN NEWKIRK; JULIA GUENTHER;
Non FDA Participant/Group: Several respresentatives from the food industry

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 04/18/2019
Location: Rockville, MD
Subject: CVM: Veterinary Issues of Mutual Interest
FDA Participant/Group: MICHAEL MURPHY; TIMOTHY SCHELL; TRACEY FORFA; WILLIAM FLYNN;
Non FDA Participant/Group: David Fairfield, Randy Gordon (National Grain and Feed Association); Joel Newman, Leah Wilkinson (American Feed Industry Association);

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event